array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(24) "Idexx Laboratories, Inc."
["slug"]=>
string(31) "52dfe-us-idexx-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62"
["description"]=>
string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities."
["address_street"]=>
string(10) "1 Idexx Dr"
["address_place"]=>
string(9) "Westbrook"
["address_region"]=>
string(5) "Maine"
["founding_date"]=>
string(10) "1983-02-28"
["website_domain"]=>
string(9) "idexx.com"
["website_url"]=>
string(21) "https://www.idexx.com"
["industry_codes"]=>
array(4) {
[0]=>
string(43) "General Livestock, Except Dairy and Poultry"
[1]=>
string(33) "Veterinary Services for Livestock"
[2]=>
string(27) "Pharmaceutical Preparations"
[3]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
}
["employee_count"]=>
int(710)
["article_count"]=>
int(640)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(83) "Elanco expands board of directors with two new directors According to Investing.com"
["snippet_en"]=>
string(60) "Elanco expands its board of directors with two new directors"
["url"]=>
string(109) "https://vn.investing.com/news/company-news/elanco-mo-rong-hoi-dong-quan-tri-voi-hai-giam-doc-moi-93CH-2108021"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2024-04-01"
["categories"]=>
array(6) {
[0]=>
string(18) "Board Compensation"
[1]=>
string(14) "Product Launch"
[2]=>
string(21) "Shareholders Feedback"
[3]=>
string(12) "Board Change"
[4]=>
string(13) "Collaboration"
[5]=>
string(18) "Expansion & Growth"
}
}
[1]=>
array(7) {
["title_en"]=>
string(61) "IDEXX's (IDXX) Global Growth Continues, Currency Woes Persist"
["snippet_en"]=>
string(132) "A key element of IDEXX's (IDXX) customer engagement strategy is the expansion of its commercial footprint in a disciplined approach."
["url"]=>
string(81) "https://finance.yahoo.com/news/idexxs-idxx-global-growth-continues-153400628.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e533ba52-2803-4968-8897-2e610b4565de"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-02-08"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[2]=>
array(7) {
["title_en"]=>
string(18) "Advancing Vet Care"
["snippet_en"]=>
string(45) "IDEXX Laboratories completes $13.5M expansion"
["url"]=>
string(69) "https://www.memphisdailynews.com/news/2011/nov/18/advancing-vet-care/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fe8a3ce8-947a-438a-ac6b-c06eb03e75b5"
["source"]=>
string(20) "memphisdailynews.com"
["publication_date"]=>
string(10) "2024-01-26"
["categories"]=>
array(3) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(24) "Access and affordability"
}
}
[3]=>
array(7) {
["title_en"]=>
string(128) "IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less th"
["snippet_en"]=>
string(138) "Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections WESTBROOK, Maine , Jan."
["url"]=>
string(162) "https://weeklyvoice.com/idexx-expands-fecal-dx-antigen-testing-platform-with-cystoisospora-detection-marking-the-second-platform-expansion-in-less-than-two-years/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/69f1b2c3-9b49-4f1c-8dc1-a723ac25cada"
["source"]=>
string(15) "weeklyvoice.com"
["publication_date"]=>
string(10) "2024-01-12"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[4]=>
array(7) {
["title_en"]=>
string(117) "IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases"
["snippet_en"]=>
string(117) "IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases"
["url"]=>
string(53) "https://www.tmcnet.com/usubmit/2023/11/08/9913650.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/32dddef2-593a-47fa-8877-995c16652277"
["source"]=>
string(10) "tmcnet.com"
["publication_date"]=>
string(10) "2023-11-08"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[5]=>
array(7) {
["title_en"]=>
string(146) "VolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters."
["snippet_en"]=>
string(299) "By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Second Quarter Highlights Nu.Q Vet Product sales of the Nu. Q Vet Canine Cancer Screening Test grew 459% YOY and 15.0% sequentially( off a low base) driven primarily by sales of reference kits through IDEXX, which launched the test"
["url"]=>
string(76) "https://finance.yahoo.com/news/volitionrx-vnrx-review-2q-2023-083000794.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/79cd5734-56b4-4df8-bd10-ec327d0b1a5d"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-08-25"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[6]=>
array(7) {
["title_en"]=>
string(54) "IDEXX, town center leading new projects in Scarborough"
["snippet_en"]=>
string(46) "Locals are waiting to see the new town center."
["url"]=>
string(110) "https://spectrumlocalnews.com/me/maine/news/2023/06/08/idexx--town-center-leading-new-projects-in-scarborough-"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0afdf307-52f7-4f23-8d6d-33c3e863c4a5"
["source"]=>
string(21) "spectrumlocalnews.com"
["publication_date"]=>
string(10) "2023-06-08"
["categories"]=>
array(2) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(7) "Opening"
}
}
[7]=>
array(7) {
["title_en"]=>
string(119) "Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network"
["snippet_en"]=>
string(228) "HENDERSON, Nev., Jan. 12, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the availability of its Nu.Q® Vet Cancer Test through the IDEXX Laboratories,"
["url"]=>
string(186) "https://www.thederrick.com/ap/business/volition-announces-expansion-of-availability-of-the-nu-q-vet-cancer-test-through-idexxs-reference/article_d5ba4047-b0b1-5a2c-98ba-e4406d69c466.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e31d0007-0263-4d9d-9366-2c2090f5ffd2"
["source"]=>
string(14) "thederrick.com"
["publication_date"]=>
string(10) "2023-01-12"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[8]=>
array(7) {
["title_en"]=>
string(128) "VolitionRx announces expansion of availability of Nu.Q Vet Cancer Test availability through IDEXX's reference laboratory network"
["snippet_en"]=>
string(135) "VolitionRx Ltd (NYSE-A:VNRX) has announced the availability of its Nu.Q Vet Cancer Test through the IDEXX Laboratories Inc reference..."
["url"]=>
string(199) "https://www.proactiveinvestors.com/companies/news/1003128/volitionrx-announces-expansion-of-availability-of-nu-q-vet-cancer-test-availability-through-idexx-s-reference-laboratory-network-1003128.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3eb2adec-149e-4e2c-adac-523e77024b35"
["source"]=>
string(22) "proactiveinvestors.com"
["publication_date"]=>
string(10) "2022-11-08"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(117)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(65)
}
[2]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(43)
}
[3]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(43)
}
[4]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(40)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(22)
}
[7]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(22)
}
[8]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(21)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(18)
}
[11]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[12]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[14]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(9)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[26]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(5)
}
}
}
52dfe-us-idexx-laboratories-inc
Idexx Laboratories, Inc.
Location
Maine
Founded
1983-02-28
Website
https://www.idexx.com
Articles
640 Articles
Category
General Livestock, Except Dairy and Poultry
Veterinary Services for Livestock
Pharmaceutical Preparations
In Vitro and In Vivo Diagnostic Substances
Description
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Second Quarter Highlights Nu.Q Vet Product sales of the Nu. Q Vet Canine Cancer Screening Test grew 459% YOY and 15.0% sequentially( off a low base) driven primarily by sales of reference kits through IDEXX, which launched the test
HENDERSON, Nev., Jan. 12, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the availability of its Nu.Q® Vet Cancer Test through the IDEXX Laboratories,
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
